Fritextsökning
Artiklar per år
Innehållstyper
-
Sprutor ska bota drogberoende
Camurus nya behandling för opiatberoende har fått klartecken att testas i fas I/II.
-
Antikropp kan stoppa bröstcancer
Bavarian Nordic rapporterar positiva resultat från fas II-studien av ett nytt bröstcancervaccin.
-
EU vill upphäva GMO-förbud
Österrike kan tvingas tillåta odling av genmodifierad majs. Detta trots att landet införde förbud mot grödan för tio år sedan.
-
Bättre koll på salmonella
Inom kort startar ett projekt för att kartlägga förekomsten av salmonella hos svenska nötkreatursbesättningar.
-
Hallå där, Christel Fenge !
...VD i nya bolaget Recipharm Biologics, som nu i eftermiddag har ovanligt många gäster i lokalerna i Södertälje.
-
A+Science söker vd
Göran Wessman lämnar sitt uppdrag. Bolagets operativa chef kliver in som tillförordnad vd medan rekrytering pågår.
-
Hårt tryck på Läkemedelsverket
Alltför många vill ansöka om Sverige som referensland i den decentraliserade processen för att godkänna läkemedel. Idag införs nya rutiner för att hantera situationen.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
BREAKING